The fact
This regulatory approval represents a major milestone in the group's drug candidate development.
Nanobiotix shares should benefit from this significant clinical advancement.
Click the link to read an article on the topic:
This regulatory approval represents a major milestone in the group's drug candidate development.
Nanobiotix shares should benefit from this significant clinical advancement.